1994. Infections following Chimeric Antigen Receptor (CAR) – T cell Therapy: 2018-2022

BACKGROUND: Chimeric Antigen Receptor (CAR) T-cell therapy is an emerging therapeutic modality for relapsing and refractory haematological malignancies. We describe the infectious complications following CAR T-cell therapy. METHODS: This is a retrospective analysis of data on patients who received C...

Descripción completa

Detalles Bibliográficos
Autores principales: Keri, Vishakh C, Ramakrishna, Jahanavi M, Vyas, Rahul, Monday, Lea M, Deol, Abhinav, Chandrasekar, Pranatharthi, Al-Saadi, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677936/
http://dx.doi.org/10.1093/ofid/ofad500.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677936/
http://dx.doi.org/10.1093/ofid/ofad500.121

Ejemplares similares